Jacob Z. Zambrzycki is an intellectual property attorney in Crowell & Moring's New York office, focusing on patent litigation and counseling. He has litigated intellectual property actions in federal district courts, including Hatch-Waxman disputes, as well as Section 337 Investigations at the U.S. International Trade Commission (ITC). Jacob's litigation experience spans from pre-suit diligence and counseling all the way through trial and appeal, including to the Federal Circuit Court of Appeals, where he has authored numerous briefs. He has represented clients across a variety of industries, including consumer electronics, automotive technologies, medical devices, financial services, electrical fittings, pharmaceuticals, and Internet technologies.
Jacob graduated from Boston College in 2005 with a bachelor of arts in computer science, focusing on software development. He received his juris doctor from Brooklyn Law School in 2009, where he was a Fellow at the Center for the Study of International Business Law.
He is a native Polish speaker.
Represented patentee, a leading manufacturer of electrical and communications products, in a district court contempt proceeding stemming from a prior patent infringement suit, resulting in a finding of contempt and an injunction against a direct competitor, and an award of lost profits and attorney fees for the patentee (M.D. Pa.).
- Represented defendant, a publicly-traded specialty pharmaceutical company, through trial, in a Hatch-Waxman district court patent infringement suit related to a generic version of Embeda®, resulting in stipulation of dismissal after trial (D. Del.)
- Represented respondent, a publicly-traded car manufacturer, in an ITC Section 337 Investigation related to automobiles with in-dash GPS navigation systems, resulting in termination of the Investigation by the complainant after six months of discovery (ITC).
- Represented defendant, a publicly-traded specialty pharmaceutical company, through trial in a Hatch-Waxman district court patent infringement suit related to a generic version of Dexilant®, resulting in a stipulated dismissal while appeal was pending (N.D. Cal.).
- Represented patentee, a leading manufacturer of electrical and communications products, in a district court patent infringement suit, obtaining a preliminary injunction prohibiting patentee's direct competitor from making, using, or selling electrical fittings accused of infringement, and subsequently obtaining a summary judgment finding of infringement. (M.D. Pa.).
- Represented complainant, a publicly-traded medical equipment manufacturer, in an ITC Section 337 Investigation related to adjustable-height hospital beds, resulting in a Consent Order whereby respondent agreed to the exclusion of accused products from entry into the United States (ITC).
Admitted to Practice: California, New York, U.S. Court of Appeals for the Federal Circuit, U.S. Court of Appeals for the Second Circuit, U.S. District Court for the Southern District of New York, U.S. District Court for the Northern District of California, U.S. District Court for the Central District of California
New York Intellectual Property Law Association
San Francisco Intellectual Property Law Association
Awards & Recognition
New York State Bar Association Empire State Counsel
Speeches & Presentations
"Medical Diagnostic Claims Are Patentable," American Health Lawyers Associations' Life Sciences Practice Group publication, Vol. 3, Issue 3
Co-Authors: Kathleen Van De Loo, Jonathan Anastasia, and Jacob Zambrzycki.
Client Alerts & Newsletters
In the News
Firm News & Announcements